Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,895
Closed -$11K 1709
2025
Q1
$11K Buy
+15,895
New +$16.2K ﹤0.01% 1589
2023
Q3
Sell
-14,132
Closed -$85K 1451
2023
Q2
$85K Buy
14,132
+10,251
+264% +$82.2K 0.01% 1392
2023
Q1
$29K Buy
+3,881
New +$38.8K ﹤0.01% 1419
2022
Q4
Sell
-7,616
Closed -$157K 1412
2022
Q3
$157K Sell
7,616
-1,741
-19% -$48.4K 0.02% 1282
2022
Q2
$259K Buy
9,357
+1,119
+14% +$38.3K 0.04% 917
2022
Q1
$360K Sell
8,238
-19,172
-70% -$833K 0.05% 758
2021
Q4
$1.51M Buy
+27,410
New +$1.69M 0.19% 72
2020
Q2
Sell
-2,323
Closed -$37K 587
2020
Q1
$37K Buy
2,323
+1,220
+111% +$29.1K 0.01% 971
2019
Q4
$30K Buy
+1,103
New +$29.5K ﹤0.01% 1379
2019
Q3
Sell
-16,652
Closed -$478K 1362
2019
Q2
$478K Buy
+16,652
New +$561K 0.05% 686

Other funds holding AFMD

GSA Capital Partners's AFMD Position: Q2 2025 in Review

GSA Capital Partners sold out of Affimed (AFMD) in Q2 2025, closing a stake of 15,895 shares — an estimated $11K sold.

GSA Capital Partners first reported a position in AFMD in Q2 2019 and held it in 10 quarters. The position peaked at $1.51M in Q4 2021. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

  • GSA Capital Partners reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 15,895 Affimed shares in Q2 2025, an estimated $11K.
  • GSA Capital Partners first reported a position in Affimed in Q2 2019 and held it in 10 quarters.
  • GSA Capital Partners's Affimed position peaked at $1.51M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.